Form 4: NeueHealth CFO Jay Matushak Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer of NeueHealth, Jay Matushak, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On May 9, 2024, Jay Matushak, CFO of NeueHealth, vested 978 restricted stock units, each representing one share of the company's common stock.
- Following the vesting, Mr. Matushak sold 317 shares on May 10, 2024, at a weighted average price of $6.05 per share to cover tax withholding obligations.
- The sales occurred in multiple transactions with prices ranging from $6.05 to $6.07 per share.
- After these transactions, Mr. Matushak directly owns 9,304 shares of NeueHealth common stock and 978 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common occurrences in publicly traded companies. It provides transparency into the trading activities of company executives.
Key Dates
| Date | Description |
|---|---|
| 05/09/2023 | One-third of the original grant amount of restricted stock units vested. |
| 05/09/2024 | Restricted stock units vested; transaction date for derivative securities. |
| 05/10/2024 | Shares sold to cover tax withholding obligations. |
| 05/09/2025 | One-third of the original grant amount of restricted stock units vests. |
| 05/13/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.